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Forceps biopsyAbstract Background: In patients with endoscopically visible lesions, ﬂexible bronchoscopy with
FB is the most frequently used technique to obtain specimens for pathologic analysis with sensitivity
of approximately 74%. The ﬂexible cryoprobe, so far used for cryotherapy and endoluminal tumor
debulking, also seemed to be suitable for biopsies from visible lesions.
Objective: The aim of this study was to prospectively evaluate the diagnostic yield and safety of
cryobiopsy and forceps biopsy.
Patients and methods: For each patient group with a conﬁrmed endobronchial lesion, diagnostic
yield and safety of forceps biopsy and cryobiopsy were recorded.
Results: The diagnostic yield was signiﬁcantly higher with cryobiopsy (95%), compared with for-
ceps biopsy (80%) (p< 0.001).
Conclusion: Cryobiopsy is a safe high diagnostic yield technique in sampling endobronchial
tumor lesions.
 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of The Egyptian Society of Chest
Diseases and Tuberculosis. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
The determination of histopathological cell type and stage of
primary lung tumor is crucial to develop an appropriate treat-
ment approach that affects morbidity and mortality. Invasive
methods widely used in histopathological diagnosis of lung
cancer are bronchoscopic mucosal biopsy, bronchial washing,
bronchial brushing, and transthoracic needle aspiration [1,2].The traditional approach to the diagnosis of visible
endobronchial disease has been through forceps biopsy (FB)
via a ﬂexible bronchoscope. Previous studies have concluded
that the diagnostic yield of bronchoscopy is augmented when
multiple procedures are performed, including brushings,
needle aspirates, and washings. Flexible bronchoscopy now
is the diagnostic tool of choice to diagnose endobronchial
malignancies [3–5].
The major drawback of the forceps biopsy technique is the
relatively small amount of tissue obtained; with a moderate
yield of sections per biopsy specimen, the mechanical damage
of the biopsy specimen, and because vital tumor tissues do not
always present further, immunohistochemical staining is
hampered [6,7].rculosis.
Table 1 Basic characteristics of the study population.
Parameter Group I Group II
N= 20 N= 20
Age (years)
Mean ± SD 53.93 ± 8.37 57.83 ± 10.88
Sex
Male 14 70% 15 75%
Female 6 30% 5 25%
Smoking history
Non smoker 5 25% 4 20%
Ex-smoker 4 20% 6 30%
Current smoker 11 55% 10 50%
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capable of obtaining large biopsy samples without causing
any morphologic alteration to the tissue samples, thereby
reducing number of additional sampling techniques required
and need for repeated bronchoscopies. Flexible cryoprobe
appears to have most of these characteristics [8,9].
The ﬂexible cryoprobe is primarily used for cryoextraction
of malignant airway stenosis and was introduced as an
alternative method for mechanical tumor debulking, which is
immediately effective [10,11]. Because of extraordinarily well-
preserved tissue samples (larger in size with less mechanical
damage and mostly vital tumor) from cryorecanalization
procedures, the technique has been transferred to the biopsy
of endobronchial lesions [12].
Aim of the study
This study aimed to evaluate the diagnostic yield and safety of
endobronchial biopsies using the ﬂexible cryoprobe, compared
to conventional forceps biopsy.
Patients and methods
This study was carried out on 40 patients with suspected endo-
bronchial malignant lesions, based on clinical diagnosis, and
enhanced C.T. chest.
Inclusion criteria
Exophytic endobronchial tumor (endoscopically visible lesion),
signed informed consent form, and sufﬁcient respiratory func-
tion (oxygen saturation >90% with 2 liters of supplementary
oxygen).
Exclusion criteria
Patient with bleeding tendency or on anticoagulant therapy,
previous cancer-speciﬁc treatment or endobronchial diagnostic
technique, O2 saturation <90% onP2 L/min, or recent severe
unstable cardiac diseases.
Patients with endoscopically visible lesion were randomized
into 2 groups (using 2 closed envelops with one selected for
randomization):
Group I: Included 20 patients in whom biopsy was carried
out using forceps biopsy (2 samples).
Group II: Included 20 patients in whom biopsy was carried
out using cryobiopsy (one sample).
Bronchoscopy and biopsy
Both procedures were carried out during ﬂexible bron-
choscopy. The patients were deeply sedated with intravenous
midazolam and local anesthesia was achieved with 10% xylo-
caine solution. Before biopsy sampling, a bronchoscopic
assessment of patients’ bronchial systems was performed.
The forceps biopsy, two biopsies, was performed conven-
tionally (using a reusable fenestrated forceps FB-21C or FB-
52C-1, Olympus Corp, Hamburg, Germany). For cryobiopsy,
a cryoprobe was used with carbon dioxide as the cryogen. The
temperature of the probe tip was approximately 89 C(Erbokryo, ERBE Medizintechnik GmbH, Tuebingen, Ger-
many). The ﬂexible cryoprobe was placed onto the endo-
bronchial lesion, and the freezing process was started for 3–
5 s or until the ice front reached the bronchial wall. The probe
was pulled out enbloc together with the bronchoscope and the
frozen tissue sample on the probe’s tip. The tissue was then
released from the probe’s tip by thawing in a sterile 0.9%
sodium chloride water bath and placed in formalin.
Histopathology
All samples were ﬁxed in 10% formalin for at least 24 h before
pathological analysis. Using centimeters (cm), biopsies were
measured in the largest diameter prior to sectioning for micro-
scopic evaluation.
Statistical analysis
All data were expressed as median (IQR) or as numeric values
(%). The diagnostic accuracy of the cryotechnology and that
of the forceps biopsy procedures was compared with an x2 test,
and the size of the specimens obtained by cryotechnology and
forceps biopsy was compared with a t test. The level of statis-
tical signiﬁcance was set at p_0.05. All analyses were per-
formed with SPSS software (version 13.0, SPSS, Chicago, IL).
Results
A total of 40 patients with suspected endobronchial malignant
lesion were randomized into two groups, patients included in
group I underwent conventional forceps biopsy, while patients
in group II had been cryobiopsied. The characteristics of the
study population are illustrated in Table 1.
Based on enhanced CT, tumor size was classiﬁed into
tumor size more than 3 cm in the largest diameter, and tumor
size less than 3 cm Table 2. On bronchoscopy, endobronchial
lesion was conﬁrmed and localized Table 2.
Median size of biopsies with cryoprobe and forceps were
1.7 cm (0.8–2.2 cm), and 0.6 cm (0.2–1.1 cm) respectively
(p< 0.001). Furthermore, histopathological examination of
tissue samples obtained via cryobiopsy was demonstrated to
be of good quality in terms of necrosis and artifact-free sample
area, with the artifact-free tissue areas of each slide signiﬁ-
cantly larger with cryobiopsies than with forceps biopsies
(1.56 vs 0.4 cm, p< 0.001) Table 3, Figs. 1 and 2.
Table 2 Tumors site and size in both studied groups.
Group I Group II
n= 20 n= 20
N % N %
Tumor site
Rt main bronchus 4 20 6 30
Lt main bronchus 5 25 6 30
Rt UL bronchus 2 10 – 0
Rt LL bronchus 4 20 3 15
Lt UL bronchus 3 15 4 20
Lt LL bronchus 2 10 1 5
Tumor size
P3 cm 14 70 16 80
<3 cm 6 30 4 20
Table 4 Histopathologic tumor types in both studied groups.
Diagnosed lesions Group I Group II
N= 20 N= 20
N % N %
Figure 1 Small cell lung cancer (H&E 400) by cryobiopsy with
no crash artifact.
Figure 2 Small cell lung cancer (H&E 400) by forceps with
crash artifact (black arrow).
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obiopsy (95%), compared with forceps biopsy (80%)
(p< 0.001). In the ﬁve nondiagnosed cases, the deﬁnitive diag-
nosis was obtained by repeated bronchoscopy with forceps
biopsy in two cases (were included in group I), and cryobiopsy
in three cases (two cases were included in group I, and one case
in group II) (see Table 4).
In both groups, there were no reported cases of pneumoth-
orax, moderate to severe bleeding, or respiratory failure. There
was mild bleeding (i.e. needed just suction) in the cryobiopsy
group (7 cases, 35%), compared to the forceps biopsy group
(8 cases, 40%).
Discussion
This study is the ﬁrst, prospective, randomised, single blinded,
trial in our institution to assess the efﬁcacy of CB and to com-
pare it with the standard method of FB. The study demon-
strated the higher diagnostic yield using cryobiopsy rather
than forceps biopsy in sampling endobronchial malignant
lesions. Our diagnostic yield is comparable or higher than
those previously reported for both CB and FB. For FB one
reason may be related to sampling technique and the use of
deeper sedation, allowing more accurate targeting of the suspi-
cious lesion. Repeated biopsy sampling of each lesion may
have resulted in a greater volume of material, which has been
demonstrated to improve the diagnostic yield.
Our results are in accordance with other studies that
demonstrated that the cryo technique provides not only larger
but also qualitatively better specimens. Less mechanical dam-
age in the cryo method might reﬂect tissue structure preserva-
tion since during this sampling procedure, the cryoprobe only
needs to gently touch the tumor lesion. This is while forcepsTable 3 Range and median values of biopsy size and artifact
free tissue area in both studied groups.
Size of biopsy Artifact free tissue area p value
Range Median Range Median
(cm)
Group I 0.2–1.1 0.6 0.14–0.8 0.415 p< 0.001
Group II 0.8–2.2 1.7 0.73–2.03 1.56 p< 0.001
NSCLC Sq cell ca. 7 35 9 45
Adenocarcinoma 3 15 2 10
Large cell ca. 1 5 1 5
Poorly diﬀ. mixed 0 0 1 5
SCLC 3 15 5 25
Others 2 10 1 5
Total 16 80 19 95biopsy needs squeezing of the target tissue. Moreover, hemo-
static effects of clot induction in the tissue, results in an artifact
free specimen [13,14].
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diagnostic tool) to forceps biopsies showing an accuracy of
95% and 85.1%, respectively. This correlated with the larger
samples obtained by cryobiopsy, also noting greater tissue
preservation.
Additionally, Chou and colleagues [5], suggested that larger
airway tumors could be harder to diagnose by forceps biopsies.
Their reported diagnostic yield with forceps was 69.3%, much
lower than previously reported. Possibly, larger airways
tumors encased in mucus, blood, and necrotic debris may
impede the forceps from penetrating into viable diagnostic
tissue.
Schumann and colleagues [10] showed that the overall diag-
nostic yield of cryobiopsy in three seconds is 89.5%.
Biopsies performed with the cryoprobe were extremely safe,
with mild hemorrhage being the main potential complication
seen in 7 cases. In contrast to ours, Hetzel et al. reported a
comparable rate of severe bleeding of 17.8% and 18.2% for
FB and CB, respectively, although the overall bleeding rate
was signiﬁcantly higher with CB. While our study may be lim-
ited by its smaller size, one alternative explanation could be
that their cases may have been subject to more sampling or
perhaps longer freezing times. Finally, there were also no
mucosal tears complicating any of our CB. Moreover, none
of our patients were on anticoagulation medications, and all
patients had been advised to stop their antiplatelet agents
7 days prior to the bronchoscopic procedures after consulta-
tion with their cardiologists.
In conclusion, cryobiopsy via ﬂexible bronchoscopy is a
safe diagnostic tool of endobronchial lesions with a high diag-
nostic yield as demonstrated in this paper.
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